✦ LIBER ✦

Use of the dopamine receptor agonist Mirapex in the treatment of Parkinson’s disease

✍ Scribed by N. V. Fedorova; I. P. Chigir’

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 144 KB
Volume: 37
Category: Article
ISSN: 0097-0549
DOI: 10.1007/s11055-007-0050-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine receptor agonists in the therap

Dopamine receptor agonists in the therapy of Parkinson’s disease

✍ P. Foley; M. Gerlach; K. L. Double; P. Riederer 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 424 KB

Selective D-1 dopamine receptor agonist

Selective D-1 dopamine receptor agonist treatment of parkinson's disease

✍ A. Braun; G. Fabbrini; M. M. Mouradian; C. Serrati; P. Barone; T. N. Chase 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 502 KB

Dopamine agonist-based strategies in the

Dopamine agonist-based strategies in the treatment of Parkinson’s disease

✍ Angelo Antonini; Paolo Barone 📂 Article 📅 2008 🏛 Springer Milan 🌐 English ⚖ 112 KB

Treatment of parkinson's disease with th

Treatment of parkinson's disease with the partial dopamine agonist EMD 49980

✍ Daniele Bravi; Thomas L. Davis; M. Maral Mouradian; Dr. Thomas N. Chase 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

## Abstract The motor effects of the partial dopamine agonist EMD 49980 were evaluated in parkinsonian patients under controlled conditions. EMD 49980 monotherapy resulted in a mild improvement in parkinsonian symptoms, but when co‐administered with levodopa, had no significant effect on dyskinesia

Treatment of Parkinson's disease should

Treatment of Parkinson's disease should begin with a dopamine agonist

✍ Jean Louis Montastruc; Olivier Rascol; Jean-Michel Senard 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

Treatment of Parkinson's disease should

Treatment of Parkinson's disease should begin with a dopamine agonist

✍ Jean-Louis Montastruc 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views